PO-41: Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial?. Issue 213 (May 2022) - Petit, B.; Soudet, S.; Poenou, G.; Zarrat, E.; Machuron, T.; Accassat, S.; Plaisance, L.; Helfer, H.; Mismetti, V.; Le Hello, C.; Sevestre, M.-A.; Mahé, I.; et al.